0 penilaian0% menganggap dokumen ini bermanfaat (0 suara)
33 tayangan1 halaman
FETAL movement Begins at 18-20 weeks; peaks at 29-38 weeks. FETAL HEART RATE 120 160 beats per minute Heard and counted as early as 8 12 weeks by Ultrasonic Doppler technique. MATERNAL SERUM ALPHA-FETOPROTEIN Alpha-fetoprotein is produced by the fetal liver; present in amniotic fluid and maternal serum.
FETAL movement Begins at 18-20 weeks; peaks at 29-38 weeks. FETAL HEART RATE 120 160 beats per minute Heard and counted as early as 8 12 weeks by Ultrasonic Doppler technique. MATERNAL SERUM ALPHA-FETOPROTEIN Alpha-fetoprotein is produced by the fetal liver; present in amniotic fluid and maternal serum.
Hak Cipta:
Attribution Non-Commercial (BY-NC)
Format Tersedia
Unduh sebagai DOCX, PDF, TXT atau baca online dari Scribd
FETAL movement Begins at 18-20 weeks; peaks at 29-38 weeks. FETAL HEART RATE 120 160 beats per minute Heard and counted as early as 8 12 weeks by Ultrasonic Doppler technique. MATERNAL SERUM ALPHA-FETOPROTEIN Alpha-fetoprotein is produced by the fetal liver; present in amniotic fluid and maternal serum.
Hak Cipta:
Attribution Non-Commercial (BY-NC)
Format Tersedia
Unduh sebagai DOCX, PDF, TXT atau baca online dari Scribd
Y From the Greek term O for O & for Y Begins at 18-20 weeks; peaks at 29-38 weeks
Y uask mother to lie in left Y spiration of amniotic fluid from the pregnant recumbent position after a meal & record number of uterus for examination fetal movements in an hour) Y an be done as early as 12th ʹ 13th week of Y è
u ount-to-Ten; records the interval it pregnancy takes for her to feel 10 fetal movements) Y equires only 1ml of fluid for analysis Y Performed to determine genetic disorders, the sex of Y 120 ʹ 160 beats per minute the fetus, & fetal lung maturity Y ÿeard & counted as early as 8 ʹ 12 weeks by Y -% !
! "#
1.Y Oaternal ÿemorrhage Y
uassessment of the Fÿ in 2.Y nfection terms of baseline & long & short-term variability) 3.Y h isoimmunization Y |
umeasures the response of Fÿ to 4.Y bruptio placentae fetal movement) 5.Y mniotic fluid emboli Y è
ufetal heart rate is analyzed 6.Y rritation of the fetus ї premature labor in conjunction with contractions) Y # &
'
%
1.Y btain informed consent
$% 2.Y nstruct the client to empty the bladder before the 1.Y iiagnose pregnancy as early as 6 weeks gestation procedure 2.Y onfirm the presence, size, & location of the 3.Y Place the client in supine position, draping placenta & amniotic fluid appropriately 3.Y Establish that fetus is ј in size & has no gross 4.Y Prepare the client for ultrasound, which is defects performed to locate the placenta 4.Y Establish the presentation & position of the fetus 5.Y btain baseline V/S & Fÿ , & monitor every 15 usex can be diagnosed if a penis is revealed) minutes 5.Y Predict maturity by measurement of the biparietal 6.Y bdomen will be washed with antiseptic solution & diameter local anesthetic will be applied 6.Y Used to discover complications of pregnancy 7.Y Warn the client that she may feel a sensation of Y ntermittent sound waves of high frequency are pressure as the needle used for aspiration, a 3- or 4- projected toward the uterus by a transducer placed inch, 20- to 22 gauge spinal needle, is introduced on the abdomen 8.Y io not suggest she take a deep breath & hold it as a Y # &
'
% distraction against discomfort 1.Y The woman usually needs to have a full bladder to 9.Y 30 minutes after the procedure, assess Fÿ & obtain a better image of the fetus uterine contractions 2.Y nstruct to drink a full glass of water before the 10.Y h-negative women may be given hoGO for risks procedure; instruct not to void before the procedure related to the procedure 3.Y nform the client that the test presents no known 11.Y nstruct the client that if chills, fever, leakage of fluid risks to the client or fetus at the needle insertion site, A fetal movement, or
()( uterine contractions occur, she is to notify the Y lpha-fetoprotein is produced by the fetal liver; physician or health care provider present in amniotic fluid and maternal serum *. (c/ Y ј in maternal serum ʹ open spinal or abdominal Y Protein components of the lung enzyme surfactant nd th defect that the alveoli begin to form about the 22 ʹ 24 Y A - chromosomal defect weeks of pregnancy Y Begins to rise at 11 weeks͛ gestation then steadily ј Y ietermined quickly by shake test or sent for until term laboratory analysis th Y Traditionally assessed at the 15 week of pregnancy Y |ormal: 2:1 Y # &
'
% (/ *( 1.Y Explain that the level is determined by a single Y ombines 4 ʹ 6 parameters: fetal breathing maternal blood sample drawn at 15 ʹ 18 weeks͛ movements, fetal movement, fetal tone, amniotic gestation fluid volume, fetal heart reactivity, & placental grade 2.Y f the level is elevated & the gestation is less than 18 Y Each item has a potential scoring of 2, highest is a 12 nd weeks͛ gestation, a 2 sample is drawn Y Oore accurate in predicting fetal well-being than any 3.Y n ultrasound is performed for elevated levels to single assessment rule out fetal abnormalities or multiple gestation Y Similar to
at birth ї
( * c Y Oay be done as often as daily during high-risk Y nalysis of 3 indicators: maternal serum for alpha- pregnancy fetoprotein, unconjugated estriol, human chorionic Y Score is 8 ʹ 12 ї fetus is doing well gonadotropin Y Score of 4 ʹ 6 ї fetus is in jeopardy Y oield more reliable results Y O
ї 2 assessments: Y equires only a single venipuncture amniotic fluid index & nonstress test * *
(c+* , Y Biopsy & analysis of chorionic villi for chromosome analysis Y ione at 10 ʹ 12 weeks of pregnancy Y è